Higher Doses Safely Led to Greater Weight Loss In New Study

• Researchers say increased doses of semaglutide weight reduction drugs may be efficient in serving to deal with weight problems.
• In two new research, the researchers reported that folks taking 7.2 mg doses of semaglutide misplaced extra weight than individuals who took smaller doses or acquired a placebo.
• Whereas GLP-1 drugs might help with weight reduction, specialists suggest a wholesome way of life that features a balanced food regimen and every day train for wholesome weight administration.

A considerably increased dose of weight-loss medicine containing the energetic ingredient semaglutide may be more practical in serving to folks drop extra pounds.

That’s based on two new research printed on September 14 in The Lancet Diabetes & Endocrinology journal.

In each scientific trials, individuals who acquired a triple dose of semaglutide remedy achieved barely extra weight reduction than folks taking an ordinary dose.

The burden loss was extra important when in comparison with examine individuals who got a placebo.

In each trials, individuals had been suggested on way of life components resembling food regimen and train. Novo Nordisk, the producer of semaglutide drugs like Ozempic and Wegovy, funded each trials.

The first study concerned 1,407 folks with obesity who didn’t have sort 2 diabetes. About 73% of the individuals had been feminine. That they had a imply age of 47 and a imply body mass index (BMI) of virtually 40.

The individuals had been adopted between January 2023 and November 2024 at 95 medical services in 11 international locations.

Nearly all of the individuals had been prescribed to a routine involving 7.2 mg weekly doses of semaglutide remedy, triple the usual dose. The opposite topics got both 2.4 mg doses or a placebo.

In that examine, researchers reported that folks taking the 7.2 mg dose achieved a mean weight lack of 19% in comparison with a mean 16% weight reduction for these taking the two.4 mg dose and practically 4% for these given the placebo.

The researchers added that about half of the individuals on the 7.2 mg dose misplaced a minimum of 20% of their body weight whereas a 3rd misplaced a minimum of 25% of their physique weight.

In addition they reported that the upper dose group confirmed extra advantages in:

The second study concerned 512 folks identified with weight problems and kind 2 diabetes. About 52% of those individuals had been feminine.

The individuals had a mean age of 56, a imply BMI measurement of 38, and a imply HbA1c blood sugar degree of barely greater than 8. They had been studied at 68 medical services between January 2023 and Could 2023.

In that examine, researchers reported individuals on semaglutide doses of seven.2 mg achieved a mean weight lack of 13% in comparison with 10% for individuals given 2.4 mg doses and near 4% for these getting a placebo.

Researchers additionally reported that folks on the 7.2 mg doses skilled extra important reductions in waist dimension and blood sugar ranges.

In each research, researchers mentioned individuals on the upper 7.2 mg doses reported some gastrointestinal unwanted effects however that these well being points had been manageable.

The scientists mentioned additional research are warranted to find out long-term dangers in addition to advantages.

“These medicine are the simplest remedy out there presently for weight reduction. Nonetheless, if somebody meets the standards for surgical procedure, that’s much more efficient than the drugs,” mentioned Mir Ali, MD, a normal surgeon, bariatric surgeon, and medical director of MemorialCare Surgical Weight Loss Heart at Orange Coast Medical Heart in California.

“They lead to important weight reduction and enchancment in lots of well being situations associated to weight problems,” Ali instructed Healthline. “They do require long-term use as research present a excessive incidence of weight regain if discontinued.”

Dan Azagury, MD, an affiliate professor of surgical procedure and chief of the Part of Minimally Invasive and Bariatric Surgical procedure at Stanford College in California, mentioned the brand new research are encouraging information.

“This new dosing of semaglutide gives a brand new more practical choice for weight reduction, in comparison with the present maximal dose,” he instructed Healthline. “Basically more practical whereas sustaining a facet impact profile that isn’t considerably worse for the standard [gastrointestinal] unwanted effects that almost all sufferers expertise.”

Nonetheless, Azagury mentioned there was one troubling facet impact he noticed within the analysis.

“The priority right here at this new dose is the numerous enhance is dyseasthesia (which incorporates issues like pores and skin sensitivity, pores and skin ‘ache’ or ‘burning sensation’),” he mentioned. “This was considerably extra frequent than the decrease dose (22.9% vs. 6%).

“The upside of most unwanted effects for these medicine is that they disappear whenever you discontinue,” Azagury added. “On this examine, 18.7% (practically 1 in 5) sufferers who had these points nonetheless had not recovered by the tip of the examine (it’s unclear what number of of these had stopped the remedy or not), so that’s one thing that can require additional research to be higher characterised.”

Ali famous that the recommended dose by the Meals and Drug Administration (FDA) for a semaglutide drug is 2.4 mg taken weekly, so a better dose can be exterior these boundaries.

“These drugs, like all drugs do have unwanted effects, a few of which may be severe. If a affected person is on a a lot increased dose, they’ve an elevated danger for extra important unwanted effects with long run use,” he mentioned.

“Moreover, this [higher dose] can be thought-about ‘off-label’ use of those drugs, and they’re already troublesome to get protection for via insurance coverage, so there may very well be a big out-of-pocket value for the affected person,” he added.

Ozempic and Rybelsus have been authorized to deal with sort 2 diabetes. Wegovy is authorized to be used in weight administration. Semaglutide medicine can be found as each oral tablets and injections.

One other generally used weight reduction remedy makes use of the energetic ingredient tirzepatide. Mounjaro is authorized to deal with sort 2 diabetes. Zepbound is authorized to be used in weight administration. These drugs can be found solely as injections.

Earlier studies have highlighted the effectiveness of those medicine in serving to folks drop extra pounds.

Ali careworn that weight reduction drugs and surgical procedure are merely instruments to assist somebody of their weight reduction journey.

He mentioned in the event that they don’t undertake a more healthy way of life that features a balanced food regimen, every day train, and adequate sleep, then they gained’t be capable of meet their weight reduction targets.

“The purpose of any weight reduction intervention, whether or not it’s drugs, surgical procedure, or simply counseling, is to supply instruments to alter to a more healthy way of life and food regimen,” Ali defined. “If sufferers don’t make these important, long-term modifications, then no intervention will stay efficient for an prolonged time frame.”

“Weight reduction medicine are handiest as a part of a complete administration,” he mentioned. “In our heart, for instance, sufferers prescribed these drugs may also see our dietitians and be given entry to assets and proposals for food regimen change, train, and so forth. Additionally it is necessary to have [a] follow-up to adapt remedy alongside the way in which.”